Management and socioeconomic development expert Leandro ‘Leo’ Pongeluppe and colleagues found that switching from paper to electronic medical records at HIV clinics in Malawi led to an estimated 28% reduction in deaths after five years, with the greatest impact on children.

Women with severe coronary heart disease causing narrowing or blockages in the arteries may derive greater long-term benefits from coronary artery bypass grafting compared with percutaneous coronary intervention, also known as stenting, according to a large study by Weill Cornell Medicine investigators.

About The Study: According to the results of this population-based surveillance study, during 2024-2025, both maternal respiratory syncytial virus (RSV) vaccine and nirsevimab were estimated to be effective at protecting infants from RSV-associated hospitalizations in their first RSV season, and RSV-associated hospitalization rates in newborns and infants ages 0 to 11 months were reduced by up to half compared to seasons before these products were introduced. 

A new study from researchers at MIT and elsewhere reveals how a high-fat diet rewires liver cells and makes them more susceptible to becoming cancerous.

About The Study: In this cohort study of the U.S. Medicare population, specific fine particulate matter (PM2.5) components (sulfate, elemental carbon, and soil dust) were associated with increased depression risk in older adults, particularly those with preexisting comorbidities. These findings underscore the importance of targeted regulation of harmful PM2.5 components to protect vulnerable populations.

About The Study: This cohort study found that the U.S. health care system imposes cost burdens on a larger share of the population than suggested by cross-sectional analyses, and most individuals in the U.S. will experience such burdens during their lifetimes. Policies that reduce out-of-pocket costs might improve the well-being of individuals in the U.S. 

About The Study: In this meta-analysis, nirsevimab was associated with reduced lower respiratory tract infection-related hospitalizations and emergency department visits in infants and young children. These findings support nirsevimab’s potential to reduce respiratory-related morbidity in young children and health care utilization.